Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$2.8B
30M shares
52-week range
$32.21 – $170.87
47% from low
Sector
SERVICES-HEALTH SERVICES
Exchange
NASDAQ
CS
P/S (TTM)
6.4
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
www.genedx.comNo one on the platform currently holds WGS.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 153,716 | $9.9M |
| Execution date | Ratio |
|---|---|
| 2023-05-04 | 1-for-33reverse |
No one on the platform has traded WGS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| Rev. Growth % | 40.0% | 19.0% | ||||
| Profit Margin % | -4.9% | -91.7% | ||||
| Free Cash Flow Margin % | 3.3% | -68.2% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +108.5% on the P/E track.
At today's price, your expected annual return is +119.6% on the P/E track.
At today's price, your expected annual return is +129.6% on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $482M | +12.9% | $0.10 | $0.10–$0.10 | 974.2× | 4 |
| 2027 | $599M | +24.2% | $1.17 | $1.12–$1.22 | 83.4× | 4 |
| 2028 | $749M | +25.2% | $1.84 | $-3.23–$6.90 | 53.0× | 2 |
| 2029 | $865M | +15.5% | $3.02 | $2.90–$3.15 | 32.3× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-03 | $-0.19 | $0.01 | +105.3% |
| 2026-05-04 | $-0.06 | $-0.28 | -366.7% |
| 2026-02-23 | $0.11 | $0.14 | +27.3% |
| 2025-10-28 | $0.28 | $0.49 | +75.0% |
| 2025-07-29 | $0.10 | $0.50 | +400.0% |
| 2025-04-30 | $0.11 | $0.28 | +154.5% |
| 2025-02-18 | $0.04 | $0.70 | +1650.0% |
| 2024-10-29 | $-0.19 |
| $0.04 |
| +121.1% |
| $9.6B |
| — |
| NAMSNewAmsterdam Pharma Company N.V. | $21.18 | +0.09% | $2.5B | — |
| OPCHOption Care Health, Inc. | $24.47 | +4.04% | $3.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
$WGS 50 day approaching 200 pushing up at 100 Fibonacci. Next resistance at 107 level. LFG🚀🚀🚀
View on StockTwits ↗
@Jblack500 @cynicaloptimist @BustaCapital @IsabellaDC @WAJeff @No_Face_character $TWST ing time again $RVTY - been nice and $WGS too
View on StockTwits ↗
$WGS the market isn’t giving this much room to breathe lower.
View on StockTwits ↗$WGS +4.9 - eyeing century again $RVTY +11.7 - new 52wh$ today
View on StockTwits ↗
@Jblack500 @IsabellaDC @BustaCapital @WAJeff @cynicaloptimist @No_Face_character $WGS - steady
View on StockTwits ↗
Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.